KNSA insider trading
Kiniksa Pharmaceuticals International, plc
In the past 68 days, 5 insiders sold $78.2M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Michael R Megna CHIEF ACCOUNTING OFFICER |
$1.1M 11,280 sh @ $98.54 |
−47.0% | Pre-scheduled | Nov 9, 2026 Filed Nov 12, 2026 |
Sanj K Patel CHAIRMAN & CEO |
$14.3M 151,300 sh @ $94.71 |
−16.3% | Pre-scheduled | Nov 4, 2026 Filed Nov 6, 2026 |
Mark Ragosa CHIEF FINANCIAL OFFICER |
$3.4M 36,783 sh @ $92.16 |
−63.8% | Pre-scheduled | Nov 2, 2026 Filed Nov 3, 2026 |
Sanj K Patel CHAIRMAN & CEO |
$37.4M 402,494 sh @ $92.92 |
−34.0% | Pre-scheduled | Oct 30, 2026 Filed Nov 3, 2026 |
Ross Moat CHIEF OPERATING OFFICER |
$9.6M 103,585 sh @ $92.93 |
−91.0% | Pre-scheduled | Oct 30, 2026 Filed Nov 3, 2026 |
John F. Paolini CHIEF MEDICAL OFFICER |
$8.9M 96,000 sh @ $93.09 |
−57.9% | Pre-scheduled | Oct 30, 2026 Filed Nov 3, 2026 |
Michael R Megna CHIEF ACCOUNTING OFFICER |
$3.4M 36,260 sh @ $94.43 |
−74.1% | Pre-scheduled | Oct 30, 2026 Filed Nov 3, 2026 |
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.